Leap Therapeutics (LPTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist

2.2000
+0.0300+1.38%

Close Jul 26 16:00 ET

2.2000
0.00000.00%

Post 16:00 ET

84.18MMarket Cap-1760P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Leap and Samsung SmartThings Deploy Automated Virtual Power Plant Solutions
BusinesswireJul 23 09:02 ET
Leap Therapeutics Initiated at Buy by Rodman & Renshaw
Dow JonesJun 28 12:56 ET
Rodman & Renshaw Initiates Leap Therapeutics(LPTX.US) With Buy Rating, Announces Target Price $8
Moomoo NewsJun 28 07:33 ET · Ratings
Leap and SWTCH Energy Launch New Virtual Power Plant Solutions for Multi-Tenant EV Charging Infrastructure
BusinesswireMay 30 09:03 ET
Buy Rating Affirmed for Leap Therapeutics on Strong Trial Prospects and Solid Financials
TipRanksMay 16 04:19 ET
Leap Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMay 14 08:00 ET

Comments

Trytosaveabit

Apr 19 16:00

Nice! And interesting to boot!

$Leap Therapeutics(LPTX.US)$ Leap Therapeutics 13G Filing Shows Gilead Sciences, Inc. Reported A 13.9% Stake In The Co As Of April 10, 2024

amiable Hedgehog_758

Apr 12 16:58

April 11
Leap Therapeutics announced it has entered into a securities purchase agreement with a select group of institutional investors to issue and sell an aggregate of 12.66M shares of its common stock at a price of $2.82 per share and pre-funded warrants to purchase 1.52M shares of common stock at a price of $2.819 per share of common stock issuable upon exercise of the pre-funded warrants, in a private placement. Leap anticipates the gross proceeds from the private placement will be approxi...

Trytosaveabit

Apr 11 11:50

$Leap Therapeutics(LPTX.US)$ Was just curious if any followers caught this? If so congrats and hope you secured profits 🥂💵

Jaguar8

Apr 11 07:32

$Leap Therapeutics(LPTX.US)$
NEWS
LEAP THERAPEUTICS ANNOUNCES $40 MILLION PRIVATE PLACEMENT
INTENDS TO USE NET PROCEEDS FROM FINANCING TO FUND CONTINUED DEVELOPMENT OF ITS LEAD MONOCLONAL ANTIBODY PROGRAM, DKN-01

Trytosaveabit

Apr 11 07:32

News

$Leap Therapeutics(LPTX.US)$ Leap Therapeutics Announces $40 Million Private Placement

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

LPTX Leap Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target